| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Over the last 12 months, insiders at Cardio Diagnostics Holdings, Inc. have bought $0 and sold $0 worth of Cardio Diagnostics Holdings, Inc. stock.
On average, over the past 5 years, insiders at Cardio Diagnostics Holdings, Inc. have bought $45,044 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 34,075 shares for transaction amount of $9,763 was made by Philibert Robert (Chief Medical Officer) on 2024‑09‑06.
| 2024-09-06 | Philibert Robert | Chief Medical Officer | 34,075 0.0794% | $0.29 | $9,763 | -3.45% | ||
| 2024-09-06 | Dogan Meeshanthini | Chief Executive Officer | 68,965 0.1627% | $0.29 | $20,000 | -3.45% | ||
| 2024-09-06 | Dogan Timur | Chief Technology Officer | 68,965 0.1627% | $0.29 | $20,000 | -3.45% | ||
| 2023-12-31 | Levy Oded | director | 0 – | $0 | $0 | -78.91% | ||
| 2023-09-30 | Levy Oded | director | 0 – | $0 | $0 | +114.02% | ||
| 2023-09-30 | Intrater James | director | 0 – | $0 | $0 | +114.02% | ||
| 2023-08-31 | Dogan Timur | Chief Technology Officer | 16,481 0.0731% | $0.55 | $8,982 | +32.30% | ||
| 2023-08-31 | Dogan Meeshanthini | Chief Executive Officer | 16,481 0.0731% | $0.55 | $8,982 | +32.30% | ||
| 2023-08-28 | Philibert Robert | Chief Medical Officer | 18,000 0.0878% | $0.60 | $10,795 | +31.82% | ||
| 2023-08-25 | Dogan Timur | Chief Technology Officer | 1,770 0.008% | $0.56 | $982 | +35.47% | ||
| 2023-08-25 | Dogan Meeshanthini | Chief Executive Officer | 1,770 0.008% | $0.56 | $982 | +35.47% | ||
| 2023-08-24 | Philibert Robert | Chief Medical Officer | 16,000 0.0781% | $0.60 | $9,600 | +23.54% |
| Philibert Robert | Chief Medical Officer | 1683867 56.8976% | $2.69M | 3 | 0 | +27.68% |
| Dogan Meeshanthini | Chief Executive Officer | 1655429 55.9367% | $2.65M | 3 | 0 | +33.89% |
| Dogan Timur | Chief Technology Officer | 197310 6.6671% | $315,696.00 | 3 | 0 | +33.89% |
| Intrater James | director | 0 0% | $0 | 1 | 0 | |
| Levy Oded | director | 0 0% | $0 | 2 | 0 |
$6,974,678 | 45 | -14.98% | $4.63M | |
$633,070 | 27 | -5.89% | $2.04M | |
$63,749,694 | 24 | -12.24% | $6.4M | |
$287,718 | 15 | -41.45% | $5.68M | |
$1,246,170 | 12 | 65.67% | $5.42M |
| Increased Positions | 6 | +35.29% | 23,330 | +20.27% |
| Decreased Positions | 6 | -35.29% | 8,886 | -7.72% |
| New Positions | 3 | New | 994 | New |
| Sold Out Positions | <1 | Sold Out | 116 | Sold Out |
| Total Postitions | 17 | 0% | 129,536 | +12.55% |
| Blackrock, Inc. | $101.00 | 1.78% | 35,567 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $69.00 | 1.21% | 24,124 | +11,442 | +90.22% | 2025-09-30 |
| Citadel Advisors Llc | $55.00 | 0.98% | 19,520 | +19,520 | New | 2025-09-30 |
| Drw Securities, Llc | $52.00 | 0.91% | 18,165 | +18,165 | New | 2025-09-30 |
| Geode Capital Management, Llc | $43.00 | 0.76% | 15,098 | +1,733 | +12.97% | 2025-09-30 |
| Pnc Financial Services Group, Inc. | $4.00 | 0.07% | 1,350 | 0 | 0% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $2.00 | 0.04% | 788 | +688 | +688% | 2025-09-30 |
| Morgan Stanley | $0 | 0.01% | 123 | +23 | +23% | 2025-09-30 |
| Cwm, Llc | $0 | 0.01% | 116 | 0 | 0% | 2025-09-30 |
| Wolverine Asset Management Llc | $0 | 0.01% | 104 | 0 | 0% | 2025-09-30 |